Status:

COMPLETED

Clinical Decision Support to Prevent Suicide

Lead Sponsor:

Vanderbilt University Medical Center

Conditions:

Suicide, Attempted

Suicidal Ideation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Suicide kills 132 Americans every day. The first step of suicide prevention is risk identification and prognostication. Researchers like this study team have developed and validated predictive models ...

Detailed Description

The investigators seek to study if identifying patients at high predicted risk of suicide in clinical settings where suicide risk screening only happens sporadically, if at all, will improve face-to-f...

Eligibility Criteria

Inclusion

  • \> 18 years of age
  • A visit in Neurology (first phase) or other non-mental health specialty setting at VUMC (second phase)

Exclusion

  • 1\) A CSSRS conducted within one week of the visit in another care setting at VUMC (recent screening)

Key Trial Info

Start Date :

August 16 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 16 2023

Estimated Enrollment :

596 Patients enrolled

Trial Details

Trial ID

NCT05312437

Start Date

August 16 2022

End Date

February 16 2023

Last Update

March 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37203